3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
4
Recruiting
2
Withdrawn
1
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Stomatitis
3
Radiodermatitis
1
Oral Ulcer
1
Neuralgia
1
Neoplasms
1
Mucositis
1
Head and Neck Neoplasms
1
Breast Neoplasms
1
Interventions
Exercise
8
Standard of Care
5
trametinib
3
tislelizumab
3
Radiotherapy
3
Radiosurgery
3
Palliative Care
3
Paclitaxel
3
Gemcitabine
3
130-nm albumin-bound paclitaxel
3
trastuzumab deruxtecan
2
cemiplimab
2
Therapeutics
2
Surveys and Questionnaires
2
Resistance Training
2
Oxaliplatin
2
Nivolumab
2
Maintenance
2
Immune Checkpoint Inhibitors
2
Drug Therapy
2
Cisplatin
2
Carboplatin
2
vedolizumab
1
toripalimab
1
surufatinib
1
sparsentan
1
sintilimab
1
semaglutide
1
posaconazole
1
pomalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasms
×
Low-Level Light Therapy
×
Clear all
NCT07372443
2026-01-28
PBMOM-PEDMX
Universidad de Guanajuato
Phase NA
Not yet recruiting
49 enrolled